Victory Capital Management
ANIK icon

Victory Capital Management’s Anika Therapeutics ANIK Stock Holding History

Victory Capital Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,866
Closed -$309K – 2703
2022
Q2 		$309K Buy
13,866
+622
+5% +$13.9K ﹤0.01% 2225
2022
Q1 		$285K Buy
13,244
+3,805
+40% +$116K ﹤0.01% 2315
2021
Q4 		$338K Sell
9,439
-159
-2% -$6.36K ﹤0.01% 2340
2021
Q3 		$408K Sell
9,598
-1,183
-11% -$48.7K ﹤0.01% 2276
2021
Q2 		$467K Sell
10,781
-2,851
-21% -$121K ﹤0.01% 2238
2021
Q1 		$556K Sell
13,632
-226
-2% -$8.57K ﹤0.01% 2154
2020
Q4 		$627K Buy
13,858
+206
+2% +$7.82K ﹤0.01% 1963
2020
Q3 		$483K Buy
13,652
+2,832
+26% +$102K ﹤0.01% 1972
2020
Q2 		$408K Sell
10,820
-15,334
-59% -$505K ﹤0.01% 2053
2020
Q1 		$756K Buy
26,154
+15,389
+143% +$622K ﹤0.01% 1946
2019
Q4 		$558K Buy
10,765
+6,213
+136% +$361K ﹤0.01% 1958
2019
Q3 		$250K Buy
+4,552
New +$234K ﹤0.01% 2140
2018
Q3 		– Sell
-5,826
Closed -$186K – 1792
2018
Q2 		$186K Buy
5,826
+798
+16% +$32.9K ﹤0.01% 1634
2018
Q1 		$250K Buy
5,028
+1,009
+25% +$57K ﹤0.01% 1539
2017
Q4 		$217K Buy
4,019
+348
+9% +$19.3K ﹤0.01% 1534
2017
Q3 		$213K Sell
3,671
-389
-10% -$20.3K ﹤0.01% 1496
2017
Q2 		$200K Buy
4,060
+608
+18% +$28K ﹤0.01% 1446
2017
Q1 		$150K Buy
3,452
+1,402
+68% +$66.9K ﹤0.01% 1503
2016
Q4 		$100K Sell
2,050
-51
-2% -$2.36K ﹤0.01% 1553
2016
Q3 		$101K Buy
2,101
+543
+35% +$26.8K ﹤0.01% 1523
2016
Q2 		$84K Buy
1,558
+679
+77% +$32K ﹤0.01% 1359
2016
Q1 		$39K Buy
+879
New +$35.7K ﹤0.01% 1493
2015
Q3 		– Sell
-1,411
Closed -$47K – 1626
2015
Q2 		$47K Buy
+1,411
New +$50.3K ﹤0.01% 1506

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Victory Capital Management's ANIK Position: Q3 2022 in Review

Victory Capital Management sold out of Anika Therapeutics (ANIK) in Q3 2022, closing a stake of 13,866 shares — an estimated $309K sold.

Victory Capital Management first reported a position in ANIK in Q2 2015 and held it in 23 quarters. The position peaked at $756K in Q1 2020. 122 funds tracked by Wall St. Rank hold ANIK as of Q3 2022.

  • Victory Capital Management reported no remaining Anika Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 13,866 Anika Therapeutics shares in Q3 2022, an estimated $309K.
  • Victory Capital Management first reported a position in Anika Therapeutics in Q2 2015 and held it in 23 quarters.
  • Victory Capital Management's Anika Therapeutics position peaked at $756K in Q1 2020.
  • 122 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.